scispace - formally typeset
I

Ignacio M. Seropian

Researcher at Hospital Italiano de Buenos Aires

Publications -  47
Citations -  2192

Ignacio M. Seropian is an academic researcher from Hospital Italiano de Buenos Aires. The author has contributed to research in topics: Myocardial infarction & Heart failure. The author has an hindex of 20, co-authored 40 publications receiving 1804 citations. Previous affiliations of Ignacio M. Seropian include Virginia Commonwealth University.

Papers
More filters
Journal ArticleDOI

The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse

TL;DR: The presence of the inflammasome in the mouse heart in an experimental mouse model of AMI as evidenced by increased caspase-1 activity and cytoplasmic aggregates of the three components of theInflammasomes may represent a unique therapeutic strategy to limit cell death and prevent heart failure after AMI.
Journal ArticleDOI

Anti-Inflammatory Strategies for Ventricular Remodeling Following ST-Segment Elevation Acute Myocardial Infarction

TL;DR: The pathophysiological mechanisms of inflammation and ventricular remodeling after AMI are reviewed and the results of clinical trials with anti-inflammatory strategies are reviewed.
Journal ArticleDOI

Enhanced Interleukin-1 Activity Contributes to Exercise Intolerance in Patients with Systolic Heart Failure

TL;DR: It is suggested that IL-1β activity contributes to poor exercise tolerance in patients with systolic HF and identifies IL- 1β blockade as a novel strategy for pharmacologic intervention.
Journal ArticleDOI

Ascorbic acid attenuates lipopolysaccharide-induced acute lung injury.

TL;DR: Ascorbic acid administered in an interventional manner following lipopolysaccharide infusion attenuates proinflammatory, procoagulant states that induce lung vascular injury in an animal model of sepsis.
Journal ArticleDOI

Alpha-1 antitrypsin inhibits caspase-1 and protects from acute myocardial ischemia-reperfusion injury.

TL;DR: Exogenous administration of clinical grade AAT reduces caspase-1 activity in the ischemic myocardium leading to preservation of viableMyocardium and prevention of adverse cardiac remodeling.